Amplify Alternative Harvest ETF (NYSEARCA:MJ) Trading Up 1.3% – Should You Buy?

Amplify Alternative Harvest ETF (NYSEARCA:MJ)’s share price was up 1.3% during mid-day trading on Monday . The stock traded as high as $20.82 and last traded at $20.56. Approximately 52,145 shares traded hands during mid-day trading, a decline of 32% from the average daily volume of 76,402 shares. The stock had previously closed at $20.30.

Amplify Alternative Harvest ETF Stock Performance

The business’s fifty day moving average is $24.24 and its two-hundred day moving average is $30.84. The company has a market cap of $118.29 million, a P/E ratio of 16.72 and a beta of 1.25.

Institutional Investors Weigh In On Amplify Alternative Harvest ETF

Several large investors have recently modified their holdings of the business. Millennium Management LLC bought a new stake in shares of Amplify Alternative Harvest ETF in the 4th quarter valued at about $494,000. Focus Partners Wealth raised its holdings in shares of Amplify Alternative Harvest ETF by 12.7% in the 4th quarter. Focus Partners Wealth now owns 46,814 shares of the company’s stock valued at $105,000 after purchasing an additional 5,262 shares in the last quarter. Raffles Associates LP purchased a new position in shares of Amplify Alternative Harvest ETF in the 4th quarter worth approximately $1,176,000. Two Sigma Securities LLC purchased a new position in shares of Amplify Alternative Harvest ETF in the 4th quarter worth approximately $48,000. Finally, Mariner LLC grew its position in shares of Amplify Alternative Harvest ETF by 54.0% in the 4th quarter. Mariner LLC now owns 31,910 shares of the company’s stock worth $71,000 after buying an additional 11,189 shares during the last quarter.

Amplify Alternative Harvest ETF Company Profile

The ETFMG Alternative Harvest ETF (MJ) is an exchange-traded fund that is based on the Prime Alternative Harvest index. The fund tracks an index of global firms engaged in the legal cultivation, production, marketing or distribution of cannabis, cannabinoids or tobacco products. The portfolio is weighted by market cap or equally based on a proprietary system.